Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia

10Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background: One of common mechanisms in pathophysiology of chronic kidney diseases is epithelial-mesenchymal transition (EMT). On the other hand oxidative stress has been known to participate in kidney damage of diabetic nephropathy (DN). Objectives: We studied if tempol,a well-known antioxidant agent,can ameliorate EMT in DN induced in male rats. Materials and Methods: Twenty-seven male rats were equally divided in to 4 groups. Group I (control or C),group II (diabetic or D),group III (T) rats which was given tempol (100 mg/kg/day) by gavages for 28 days and group IV (D&T) was diabetic rats that also received same dose of tempol. After treatment,their kidneys were studied by immunohistochemical staining. Results: Pathological changes in the kidney were detected concurrently with increasing kidney weight and urinary albumin excretion. In addition,EMT indices,i.e. decline of E-cadherin and increase of α SMA staining were significantly emerged in the renal tubular cells of diabetic group and were partially modified in diabetic group which were simultaneously treated by tempol. Conclusions: Tempol can modify,but not significantly,EMT induced by DN.

Cite

CITATION STYLE

APA

Jafari, M., Dadras, F., Ghadimipour, H. R., Seif Rabiei, M. A., & Khoshjou, F. (2017). Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia. Journal of Nephropathology, 6(1), 1–4. https://doi.org/10.15171/jnp.2017.01

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free